| Similar Articles |
|---|
 |
Chemistry World
October 28, 2011
James Urquhart |
Simpler Enzymatic Route to Synthetic Heparin US scientists have demonstrated a potentially cheaper way of creating ultra low molecular weight heparin, a synthetic blood thinning agent primarily used to treat deep vein thrombosis and pulmonary embolism.   |
Chemistry World
August 7, 2015
Suzanne Howson |
Simple probe for heparin quality control Scientists in China have developed a fluorescent probe to detect both heparin and its major contaminant. The sensor could make it easier to monitor the quality of heparin supplies. |
The Motley Fool
April 10, 2008
Brian Orelli |
The News for Baxter Just Got Worse These heparin-related deaths aren't associated with Baxter's product, but they still might spell trouble for the company. |
Chemistry World
April 20, 2011
Jon Cartwright |
New clotting drug antidote could cut surgery risk Chemists in the UK have developed a possible alternative to protamine, a molecule used by doctors to counteract the effects of anti-clotting drugs. |
The Motley Fool
April 2, 2008
Brian Lawler |
Medicines Company Sets Itself Apart Drugmaker Medicines Company wants to distance its angioplasty treatment from heparin. |
Chemistry World
February 12, 2014
Amy Middleton-Gear |
Neutralizing heparin without complications Recovering from operations could become easier thanks to a self-assembling multivalent heparin binding agent being developed by scientists in the UK, Italy and Spain. |
The Motley Fool
March 7, 2008
Brian Lawler |
A Little Too Much Drug Variability Another drugmaker has to recall batches of its compound. |
The Motley Fool
February 29, 2008
Brian Orelli |
Bigger Recall, No Big Deal Baxter increases its recall of heparin, but investors shouldn't be that worried. |
Chemistry World
January 18, 2013
Emma Eley |
New method to target malaria Malaria affects millions of people each year; however, no effective vaccines exist. Now, scientists from Spain have discovered a new strategy to target the disease. |
Chemistry World
August 11, 2015
Emma Cooper |
Streamlined synthesis yields longer sugar chains By using bigger building blocks, scientists in the UK have shown they can make much longer oligosaccharide sequences than previously possible. |
